[Pathological nighttime fears in children: Clinical specificities and effective therapeutics]

D Ducasse1, H Denis1

  • 1Inserm U1061, hôpital La Colombière, pavillon 42, 39, avenue Charles-Flahault, BP 34493, 34093 Montpellier cedex 5, France; Université Montpellier 1, 5, boulevard Henri-IV, CS 19044, 34967 Montpellier cedex 2, France; Service universitaire de psychiatrie de l'enfant, hôpital Peyre-Plantade, hôpital La Colombière, CHRU Montpellier, 39, avenue Charles-Flahault, 34295 Montpellier cedex 5, France.

L'Encephale
|December 28, 2014
PubMed

Insights

Pathological nighttime fears in children cause significant distress and dysfunction. Effective treatments, including cognitive-behavioral techniques, are available for managing these childhood anxiety disorders.

Area of Science:

  • Pediatric Psychology
  • Child Psychiatry
  • Sleep Medicine

Background:

  • Pathological nighttime fears in children are common yet understudied.
  • These fears cause significant distress and dysfunction for children and families.
  • While often part of normal development, 10% of cases are linked to anxiety disorders.

Purpose of the Study:

  • To review the clinical features of pathological nighttime fears in children.
  • To outline assessment strategies for these conditions.
  • To identify effective treatment options for affected children and their families.

Main Methods:

  • Systematic review following PRISMA guidelines.
  • Searched Medline and Web of Science databases.
  • Included English and French language studies with no date limitations.

Main Results:

  • Nighttime fears manifest as emotional and behavioral disturbances, impacting sleep, school, and social development.
  • Assessment should rule out organic causes and identify comorbid anxiety disorders.
  • Effective treatments include systematic desensitization, reinforcement, and cognitive techniques tailored to age.

Conclusions:

  • Clinical features and assessment methods for pathological nighttime fears are detailed.
  • Effective treatments with evaluated efficacy are highlighted for this condition.
Abstract

Related Concept Videos

Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
938
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
831
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
805
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
886
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
861
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
371